Company: KEQU
Filing Date: 2025-07-02
Form Type: 10-K
Source: 0000055529-25-000026
Chunk: 194

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-07-02
Form: 10-K
Item: Item 1A
Chunk 194
---
 of the Securities and Exchange Commission that permit us to provide only management's report in this Annual Report.

Item 9B. Other Information

Securities Trading Plans of Directors and Executive Officers

Transactions in the Company's securities by its directors or executive officers are required to be made in accordance with its Insider Trading Policy, which, among other things, requires that the transaction be in accordance with applicable U.S. federal securities laws that prohibit trading while in the possession of material nonpublic information. Rule 10b5-1 under the Securities Exchange Act of 1934 provides an affirmative defense that enables prearranged transactions in securities in a manner that avoids concerns about initiating transactions at a future date while possibly in possession of material nonpublic information.

During the three months ended April 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed the Company of the adoption or termination of a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as defined in Item 408 of Regulation S-K).

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable.

53

PART III

Item 10. Directors, Executive Officers and Corporate Governance

(a)The information appearing in the sections entitled "Election of Directors" and "Meetings and Committees of the Board" included in our Proxy Statement for use in connection with our annual meeting of stockholders to be held on August 27, 2025 (the "Proxy Statement") is incorporated herein by reference. The Proxy Statement will be filed with the SEC within 120 days of our most recently completed fiscal year.

(b)The names and ages of our executive officers as of June 27, 2025 and their business experience during the past five years are set forth below: 

Executive Officers

NameAgePositionThomas D. Hull III49President and Chief Executive OfficerDonald T. Gardner III46Vice President, Finance, Chief Financial Officer, Treasurer and SecretaryRyan S. Noble47Vice President, Sales and Marketing—AmericasElizabeth D. Phillips48Vice President, Human ResourcesMandar Ranade51Vice President of Information Technology and EngineeringDouglas J. Batdorff52Vice President of Manufacturing OperationsBoopathy Sathyamurthy56Vice President, Kewaunee Scientific Corporation Singapore Pte. Ltd., Managing Director, International Operations

Thomas D.